Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q4 2025 (December 31)17holders +3
3new positions
1sold out
1famous investor
$1.03avg. 13F price*
At the end of Q4 2025, 17 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, up 3 from Q3 2025. 3 opened new positions and 1 sold out. The largest holders were Yorkville Advisors Global, LP ($398K), Gagnon Securities LLC ($89K) and Citadel Advisors ($16K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $414K |
| Exits | 1 | $37 |
All 13F filers, Q3 2025 → Q4 2025: 475,958 shares bought and 82 shares sold, net +475,876 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Yorkville Advisors Global, LP | 0.27% | New | 386,593 | $398K |
| Gagnon Securities LLC | 0.02% | Add +383.1% | 86,102 | $89K |
| Citadel Advisors | 0.00% | New | 15,477 | $16K |
| GAMMA Investing LLC | 0.00% | Add +3476.3% | 4,828 | $5K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 3,388 | $3K |
| Rhumbline Advisers | 0.00% | Add +51.5% | 2,678 | $3K |
| Bank of America Corp. | 0.00% | No change | 303 | $312 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 38 | $39 |
| Your Advocates Ltd., LLP | 0.00% | No change | 19 | $20 |
| UBS Group AG | 0.00% | Reduce -21.7% | 18 | $18 |
| Garton & Associates Financial Advisors LLC | 0.00% | — | 15 | $15 |
| Smartleaf Asset Management LLC | 0.00% | New | 5 | $5 |
| Group One Trading LLC | 0.00% | Reduce -63.6% | 4 | $4 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -93.0% | 4 | $4 |
| Vermillion Wealth Management, Inc. | 0.00% | No change | 2 | $2 |
| Morgan Stanley | 0.00% | No change | 1 | $1 |
| Royal Bank of Canada | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.